Benefits of Intravenous Iron Supplementation in Patients with Heart Failure: Mounting Evidence and Open Questions
European Journal of Heart Failure · 2023
DOI: 10.1002/ejhf.2787 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Heart Failure, 2023. Verfasst von Andreas P Kalogeropoulos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA. Hauptthemen laut MEDLINE: Heart Failure, Hematinics, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
This article refers to 'Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis' by F.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
- Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Kalogeropoulos, A. P., & Lewis, G. D. (2023). Benefits of Intravenous Iron Supplementation in Patients with Heart Failure: Mounting Evidence and Open Questions. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2787
Vancouver
Kalogeropoulos AP, Lewis GD. Benefits of Intravenous Iron Supplementation in Patients with Heart Failure: Mounting Evidence and Open Questions. European Journal of Heart Failure. 2023. doi:10.1002/ejhf.2787
BibTeX
@article{Kalogeropoulos2023,
author = {Kalogeropoulos, Andreas P and Lewis, Gregory D},
title = {Benefits of Intravenous Iron Supplementation in Patients with Heart Failure: Mounting Evidence and Open Questions},
journal = {European Journal of Heart Failure},
year = {2023},
doi = {10.1002/ejhf.2787}
}
EUVIMED